Samlyn Capital’s Nuvalent NUVL Stock Holding History

Samlyn Capital’s Portfolio NUVL Stock Details NUVL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-309,594	Closed	-$22M	–	91
2025 Q1	$22M	Sell	309,594 -443	-0.1%	-$34.6K	0.33%	66
2024 Q4	$24.3M	Buy	310,037 +28,804	+10%	+$2.69M	0.37%	71
2024 Q3	$28.8M	Buy	281,233 +51,908	+23%	+$4.31M	0.44%	67
2024 Q2	$17.4M	Buy	+229,325	New	+$16.3M	0.29%	78

Other funds holding NUVL

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Samlyn Capital's NUVL Position: Q2 2025 in Review

Samlyn Capital sold out of Nuvalent (NUVL) in Q2 2025, closing a stake of 309,594 shares — an estimated $22M sold.

Samlyn Capital first reported a position in NUVL in Q2 2024 and held it in 4 quarters. The position peaked at $28.8M in Q3 2024. 209 funds tracked by Wall St. Rank hold NUVL as of Q2 2025.

Samlyn Capital reported no remaining Nuvalent position as of Q2 2025 after selling out during the quarter.
Samlyn Capital sold 309,594 Nuvalent shares in Q2 2025, an estimated $22M.
Samlyn Capital first reported a position in Nuvalent in Q2 2024 and held it in 4 quarters.
Samlyn Capital's Nuvalent position peaked at $28.8M in Q3 2024.
209 funds tracked by Wall St. Rank held Nuvalent as of Q2 2025.

Based on Samlyn Capital's 13F filing for Q2 2025, filed 14 Aug 2025.